Dissecting complex disease: the quest for the Philosopher's Stone?

Anne V Buchanan1, Kenneth M Weiss, Stephanie M Fullerton

  • 1Department of Anthropology, Penn State University, University Park, PA 16802, USA.

Insights

Research into complex chronic diseases faces challenges due to unsuitable models and criteria. Current approaches may not align with the unique biology of these conditions, hindering prediction and prevention efforts.

Area of Science:

  • Epidemiology
  • Genetics
  • Public Health

Background:

  • Complex chronic diseases significantly impact public health globally.
  • Despite extensive research, understanding the causes of these diseases remains challenging.
  • Current progress in predicting and preventing complex diseases has been limited.

Purpose of the Study:

  • To explore the reasons behind the slow progress in complex disease research.
  • To evaluate the suitability of existing research models and causal criteria for complex diseases.
  • To question the applicability of traditional prediction and prevention paradigms to complex diseases.

Main Methods:

  • Review and discussion of current research models and methodologies.
  • Analysis of causal criteria used in disease research.
  • Examination of the inherent biological characteristics of complex diseases.

Main Results:

  • Existing models and methods, often designed for Mendelian or point-source diseases, may be inappropriate for complex diseases.
  • Causal criteria relevant for infectious diseases may not be optimal for complex chronic conditions.
  • The inherent biology of complex diseases presents unique challenges to research.

Conclusions:

  • The search for causes of complex diseases requires novel approaches.
  • Current prediction and prevention strategies may need re-evaluation for complex diseases.
  • Complex diseases may not be amenable to the same level of prediction and prevention seen with infectious or Mendelian diseases.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...